Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Kite, A Gilead Company
Scientific Title
A Phase 2 Multicenter Study Evaluating the Efficacy and Safety of Axicabtagene Ciloleucel as First-Line Therapy in Subjects With High-Risk Large B-Cell Lymphoma